Apollomics, Inc. (APLM)

Apollomics Statistics

Total Valuation

Apollomics has a market cap or net worth of $16.52 million. The enterprise value is -$4.69 million.

Market Cap	16.52M
Enterprise Value	-4.69M

Important Dates

The last earnings date was Wednesday, August 14, 2024, before market open.

Earnings Date	Aug 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Apollomics has 110.27 million shares outstanding. The number of shares has decreased by -77.42% in one year.

Current Share Class	110.27M
Shares Outstanding	110.27M
Shares Change (YoY)	-77.42%
Shares Change (QoQ)	+4.36%
Owned by Insiders (%)	24.49%
Owned by Institutions (%)	2.06%
Float	57.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.54
Forward PS	n/a
PB Ratio	0.79
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.23.

Current Ratio	2.25
Quick Ratio	2.08
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-237.40

Financial Efficiency

Return on equity (ROE) is -149.31% and return on invested capital (ROIC) is -79.94%.

Return on Equity (ROE)	-149.31%
Return on Assets (ROA)	-62.74%
Return on Capital (ROIC)	-79.94%
Revenue Per Employee	$46,689
Profits Per Employee	-$1.27M
Employee Count	45
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.29% in the last 52 weeks. The beta is 1.21, so Apollomics's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-80.29%
50-Day Moving Average	0.13
200-Day Moving Average	0.31
Relative Strength Index (RSI)	55.09
Average Volume (20 Days)	86,652,375

Short Selling Information

The latest short interest is 168,467, so 0.15% of the outstanding shares have been sold short.

Short Interest	168,467
Short Previous Month	333,682
Short % of Shares Out	0.15%
Short % of Float	0.29%
Short Ratio (days to cover)	0.17

Income Statement

In the last 12 months, Apollomics had revenue of $2.10 million and -$57.11 million in losses. Loss per share was -$0.63.

Revenue	2.10M
Gross Profit	2.10M
Operating Income	-53.18M
Pretax Income	-172.59M
Net Income	-57.11M
EBITDA	-53.10M
EBIT	-53.18M
Loss Per Share	-$0.63

Balance Sheet

The company has $25.93 million in cash and $4.72 million in debt, giving a net cash position of $21.21 million or $0.19 per share.

Cash & Cash Equivalents	25.93M
Total Debt	4.72M
Net Cash	21.21M
Net Cash Per Share	$0.19
Equity (Book Value)	20.81M
Book Value Per Share	0.19
Working Capital	15.76M

Cash Flow

In the last 12 months, operating cash flow was -$34.80 million and capital expenditures -$24,000, giving a free cash flow of -$34.82 million.

Operating Cash Flow	-34.80M
Capital Expenditures	-24,000
Free Cash Flow	-34.82M
FCF Per Share	-$0.32

Margins

Gross Margin	100.00%
Operating Margin	-2,531.08%
Pretax Margin	-2,718.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Apollomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	77.42%
Shareholder Yield	77.42%
Earnings Yield	-345.76%
FCF Yield	-210.83%

Analyst Forecast

The average price target for Apollomics is $4.25, which is 2,737.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.25
Price Target Difference	2,737.12%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Apollomics has an Altman Z-Score of -25.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-25.02
Piotroski F-Score	2